FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths / ABC News

go - The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda

US narrows use of muscle-wasting therapy after teen deaths

3 months / medicalxpress

FDA updates Sarepta’s Duchenne gene therapy label, requests postmarketing study

3 months / endpoints / Lei Lei Wu

FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths

3 months / go

Saturday, November 15, 2025, 5:21 am / permalink 15991 / 3 stories in 3 months

Related Stories

FDA Lifts Hold on Intellia’s Phase 3 Gene Editing Trial / 5 wks
FDA rejects Corcept’s cortisol modulator triggering setback / 2 months
FDA approves Rucaparib for advanced prostate cancer / 2 months
FDA approves first gene therapy for Wiskott‐Aldrich syndrome / 2 months
FDA Approves Novartis’ Itvisma Gene Therapy for SMA Across Age Groups / 3 months
FDA Approves Ziftomenib for AML Treatment / 3 months
Experimental therapy reduces seizures in children with Dravet syndrome / 5 days

Related Tags

Healthcare

Judge orders Leapfrog to remove safety grades for five Florida hospitals (22 hrs)

Daily multivitamin slows epigenetic aging in randomized COSMOS analysis (41 hrs)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

more #healthcare

Pharmaceuticals

Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity (2 days)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

Eli Lilly launches Employer Connect to broaden GLP‑1 coverage (3 days)

more #pharmaceuticals

Public Health

Judge orders Leapfrog to remove safety grades for five Florida hospitals (22 hrs)

Daily multivitamin slows epigenetic aging in randomized COSMOS analysis (41 hrs)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

more #publichealth

StackHealth Time Machine

NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.